4277 |
TAVR - Year in Review |
David Joel Cohen |
Apr. 25. 17 |
4276 |
PCI - Year in Review |
Neal S. Kleiman |
Apr. 25. 17 |
4275 |
Best from JACC/JACC Interventions in 2016 |
E Murat Tuzcu |
Apr. 25. 17 |
4274 |
Post-PCI FFR: What Does It Mean and Should We Measure It? |
William F. Fearon |
Apr. 25. 17 |
4273 |
Treating Tandem Lesions and Diffuse Disease: FFR, iFR, and Co-Registration |
Nils Johnson |
Apr. 25. 17 |
4272 |
Should iFR Replace FFR? - Results from DEFINE-FLAIR and SWEDE-HEART |
Justin E. Davies |
Apr. 25. 17 |
4271 |
OCT-Guided PCI: OPINION, DOCTORS, ILUMIEN-III and ILUMIEN-IV |
Akiko Maehara |
Apr. 25. 17 |
4270 |
IVUS-Guided PCI: Meta-Analysis, Patient Selection, Essential Technique |
Gary S. Mintz |
Apr. 25. 17 |
4269 |
BRS Failure Analysis: Lessons from Serial Imaging Studies |
Yoshinobu Onuma |
Apr. 25. 17 |
4268 |
[Satellite Lecture] PCI Outcomes with Bioresorbable Scaffolds: Role of Technique and DAPT |
Gregg W. Stone |
Apr. 25. 17 |